Figures
- Fig. 1.—
Computed tomography scan of the thorax of a patient with cystic fibrosis showing grossly-dilated bronchi.
Tables
- Table 1—
Selection criteria for transplantation in cystic fibrosis
Indications Severe respiratory failure in spite of optimal medical therapy Severely impaired quality of life Patient positively wants a transplant Strong contraindications Active aspergillus or mycobacterial infection Noncompliance with treatment Prednisolone therapy>10 mg·day−1 Other end-organ failure Gross malnutrition HIV Malignancy within 5 yrs Hepatitis B or C Burkholderia cepacia Genomovar type III Significant osteoporosis Significant osteoporosis Drug or alcohol addiction Risk factors Pre-operative ventilation (intubated) Previous thoracic surgery, especially pleurectomy Chemical pleurodesis, especially talc Severe liver disease -
HIV: human immunodeficiency virus
-
- Table 2—
Cystic fibrosis patients treated with noninvasive ventilation
Patients FEV1 L FVC L Pa,O2 kPa Pa,O2 kPa Pa,CO2 kPa Pa,CO2 kPa Pre Post Pre Post Group A (65) 0.7 (63) 1.4 (63) 6.6 (59) 8.8 (55) 10.0 (59) 9.0 (55) Group B (25) 0.7 (17) 1.4 (17) 6.4 (20) 9.9(20) 9.3 (20) 8.5 (20) Group C (23) 0.6 (20) 1.2 (20) 7.6 (20) 8.9 (21) 8.5 (19) 9.6 (19) -
Data are given as median values (n=numbers of patients on whom data was available)
-
FEV1: forced expiratory volume in one second
-
FVC: forced vital capacity
-
Pa,O2: oxygen tension in arterial blood
-
Pa,CO2: carbon dioxide tension in arterial blood
-
Correction
Correction, published in Eur Respir J 2002; 20: 790.
Files in this Data Supplement:
- Correction - Correction, published in Eur Respir J 2002; 20: 790.
Vol 19 Issue 2
Table of Contents
Noninvasive ventilation in cystic fibrosis patients with acute or chronic respiratory failure
